Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
In addition to workforce reductions, 23andMe has also decided to discontinue its therapeutic ... The situation worsened in ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
And then we'll get into the 2nd quarter in late October 23andMe reconstituted our board of directors with the appointment of three new independent directors. We are pleased that these ...
Back in September, all of 23andMe’s independent directors also resigned from its board — in a rare move that followed ...
In September, independent directors of the Board of 23andMe sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
Shares were hovering below $1 until 23andMe announced a 1-for-20 reverse stock split in October. In September, all seven of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback